SCHEMBL14722914

SCHEMBL14722914

Cc1nc(-c2ccc(C=C3CCN(C4CCC4)CC3)cc2)no1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
P2RX3 P56373 4/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
SMYD3 Q9H7B4 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PLK1 P53350 1/20 0.38
HRH3 Q9Y5N1 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
GPR119 Q8TDV5 1/20 0.37
MAPK14 Q16539 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730970 0.82 ACHE (0.42) HRH3GPR119LMNAAOC3
SCHEMBL14721566 0.81 BRD4 (0.52) HRH3
SCHEMBL14722041 0.79 HRH3 (0.52) HRH3RAB9AGPR119MAPK14NR1I2
SCHEMBL14721971 0.75 HRH3 (0.39) HRH3
SCHEMBL14721988 0.75 KDM2B (0.51) HRH3
SCHEMBL14722166 0.74 CYP11B2 (0.42) ALDH1A1HRH3SMN1; SMN2
SCHEMBL14722014 0.73 HRH3 (0.41) HRH3
SCHEMBL14722100 0.73 HRH3 (0.41) HRH3NR1I2
SCHEMBL14722714 0.73 HRH3 (0.41) HRH3
SCHEMBL5211042 0.72 DGAT1 (0.45) P2RX3HRH3L3MBTL1GPR119NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed